Impact of Surgery Time on the Clinical Efficacy and Prognosis of Elderly Patients with Hip Fractures
Objective To explore the influence of surgery time on the clinical efficacy and prognosis of elderly patients with hip fractures.Methods A retrospective analysis was conducted on the clinical data of 188 elderly patients with hip fractures who underwent surgical treatment in the Sinopharm Dongfeng General Hospital,Hubei University of Medicine from January 2022 to December 2023.According to the surgery time,patients were divided into an early surgery group of 86 cases ( ad-mission to surgery time≤48 h) and a delayed surgery group of 102 cases ( admission to surgery time>48 h) .Coagulation function indexes[activated partial thromboplastin time ( APTT),prothrombin time ( PT),fibrinogen ( FIB),fibrinogen degradation product (FDP),D-dimer (D-D)]upon admission and before and after treatment,as well as lower extremity deep vein thrombosis ( DVT) after surgery,surgery time,perioperative blood transfusion,intraoperative bleeding volume,postoperative ICU transfer,postoperative complications,and hospitalization time were compared between the two groups.Results There was no significant difference in fracture type,anesthesia method,surgical method,surgery time,and preop-erative coagulation functions between the two groups of patients ( P>0.05) .The perioperative blood transfusion,intraopera-tive bleeding volume,postoperative DVT,coagulation functions,and pressure injury in the early surgery group were lower than those in the delayed surgery group,and the hospitalization time was shorter than that in the delayed surgery group ( P<0.05) .No difference was found in postoperative incision infection,urinary system infection,myocardial infarction,and ICU transfer ( P>0.05) .Conclusion Patients undergoing early surgery have high hemodynamic stability and low postopera-tive DVT in lower limbs,with high safety,which is worthy of clinical promotion.
Surgery timeElderly patients with hip fracturesCoagulation functionLower extremity deep vein thrombosis
万方数据
维普
